Lupin Tells Rakesh Jhunjhunwala In An Interaction

Rakesh Jhunjhunwala Tips & Portfolio

The management of Lupin believes the worst is also over on drug evaluation pressures within the US, the corporate told investors in associate degree interaction when reportage its quarterly earnings.

Indias second-largest drug maker on Tuesday denote an enormous overall loss of Rs 783.5 large integer within the fourth quarter terminated March because of a one-time losses provision on created on sure intangible assets associated with the Gavis acquisition within the US.

Ace capitalist Rakesh Jhunhjhunwala, UN agency holds 1.92% stake in Lupin, was among those that quizzed the management on pricing pressure.

"I will not say that value erosion is gone however i am going to say that days of double-digit value erosion, we have a tendency to hope, area unit behind US, Vinta Gupta, corporate executive of Lupin, same throughout the speak.

Increasing competition and a consolidating client base are symptom profits at drug manufacturers activity to the US, the worlds largest attention market.

So much that several big companies, like Teva and Novartis, area unit even considering swing their generics business on the block.

"Companies have started getting out of portfolios that don't make sense, she told Jhunjhunwala throughout the decision.

Additionally, she same that customers were additionally accommodative of the very fact that the trade has reached a pain purpose and other that balance has to shift.

We are addressing pockets of our portfolio where we have pressures and are working with our channel partners, our customers to see how we can work together to ensure sustainable supply, she added.

The company reported a net profits of Rs 383.6 crore in the fourth quarter.while revenues at Rs 3,952 crore.

A Reuters poll of analysts calculable profits to Rs 323.8 large integer within the fourth quarter, whereas revenues at Rs 3,952 crore.

The company took associate degree upset of 1464.3 crore on Gavis.

Excluding one-time losses provision, the total profit of Lupin stood at Rs 358.6 crore, beyond analyst estimates.

 

ABOUT AUTHOR

Niveza Editorial Desk : We are a team of stock market nerds trying to stay ahead of the herd. We spend our grey cells everyday to a pave a smooth road for our clients in the shaky world of stock market. While tracking the mood swings of the market we bring our clients the most rewarding deals.

LEAVE A COMMENT

RECOMMENDED READING

Multibagger Penny Stocks: Risky Or Rewarding

The usual trap where every newbie investor gets trapped is multibagger penny stocks. These stocks trade at the most discounted prices. That's why investors initially fell in love with these stocks as prima facie these stocks seemed to be the hi
Read More>>

Free Share Market Tips Today: Stop & Read Before You Invest In Stocks

Various popular stock market news portals and TV channels discuss trending stocks and provide free share market tips based on technical charts and often without in-depth research. Our research desk analyses these trending stock market tips and pro
Read More>>

Share Market News: Today’s Nifty & Sensex Updates

Share Market News 21st-February-2019
Read More>>

Volatility Ahead, Stick To The Fundamentally Strong Stocks

Our Analysis This week even after the RBI's rate cut announcement the market changed its outlook from bullish to the corrective phase. The market corrected for the fifth consecutive day
Read More>>

What is Multibagger Stocks?

What is a multibagger stock? A stock which can give you manyfold returns. Yes, that's true. Multibagger stocks are defined in a similar manner. The legendary investor Peter Lynch has termed Multibagger stocks in his book One Up On Wall
Read More>>